Table S3.
Sample size and distribution for neurite retraction assay
| Genotype | Treatment | Explants (n) | Mean retraction | SEM | Dishes (n) | Animals (n) |
|---|---|---|---|---|---|---|
| Wild type | Control | 12 | −8.7% | 6.1% | 5 | 4* |
| Wild type | 1 nM LPA | 17 | 47.5% | 4.2% | 6 | 5* |
| Wild type | 10 nM LPA | 20 | 80.1% | 5.9% | 9 | 6* |
| Wild type | 100 nM LPA | 25 | 97.2% | 0.7% | 9 | 7* |
| Lpar2 | 10 nM LPA | 13 | 81.1% | 3.3% | 5 | 4 |
| Lpar1 Lpar2 | 10 nM LPA | 21 | 78.4% | 4.2% | 7 | 6 |
| Lpar1 Lpar2 Lpar3 | 10 nM LPA | 3 | 63.4% | 22.9% | 1 | 1 |
Note: Total number of explants analyzed (n) for each condition along with the mean retraction (%), where negative retraction would be growth, and SEM. In addition, the total number of dishes analyzed as well as the number of animals analyzed for each condition is indicated.
For wild type analysis, each experiment represented one or more animals whose retinas were removed and explants pooled for analysis; thus, the number of animals indicated is the number of independent experiments, which is a minimum number of animals.
Abbreviations: LPA, lysophosphatidic acid; SEM, standard error of mean.